Suchergebnisse - "Raviglione, Mario"

PubPharm (7)

1

Towards comprehensive clinical trials for new tuberculosis drug regimens : policy recommendations from a stakeholder analysis

enthalten in: BMJ global health | 2024

von Villa, S. | de Colombani, P. | Dall'Olio, L. | +2

2

Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis : a commentary on the proposed EU pharma regulation

enthalten in: BMJ global health | 2024

von Berner-Rodoreda, A. | Cobelens, F. | Vandamme, A. | +7

3

Waiting for the truth : is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?

enthalten in: BMJ global health | 2022

von Canuti, M. | Bianchi, S. | Kolbl, O. | +10

4

Build back stronger universal health coverage systems after the COVID-19 pandemic : the need for better governance and linkage with universal social protection

enthalten in: BMJ global health | 2020

von Tediosi, F. | Lönnroth, K. | Pablos-Méndez, A. | +1

5

Where is the 'global' in the European Union's Health Research and Innovation Agenda?

enthalten in: BMJ global health | 2019

von Berner-Rodoreda, A. | Rehfuess, E. | Klipstein-Grobusch, K. | +17

6

Where is the ‘global’ in the European Union’s Health Research and Innovation Agenda?

enthalten in: BMJ global health | 25 August 2019

von Berner-Rodoreda, A. | Rehfuess, E. | Klipstein-Grobusch, K. | +17

7

The Internet of Things to come : digital technologies and the End TB Strategy

enthalten in: BMJ global health | 2016

von Falzon, D. | Raviglione, M.

1
[1]